Cargando…
The current evidence base for the feasibility of 48-hour continuous subcutaneous infusions (CSCIs): A systematically-structured review
BACKGROUND: A continuous subcutaneous infusion (CSCI) is an effective method of multiple drug administration commonly encountered in end of life care when the oral route is compromised. At present, current practice is to limit syringe driver infusion time to a maximum of 24 hours as dictated by avai...
Autores principales: | Baker, James, Dickman, Andrew, Mason, Stephen, Ellershaw, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851608/ https://www.ncbi.nlm.nih.gov/pubmed/29538455 http://dx.doi.org/10.1371/journal.pone.0194236 |
Ejemplares similares
-
An evaluation of continuous subcutaneous infusions across seven NHS acute hospitals: is there potential for 48-hour infusions?
por: Baker, J., et al.
Publicado: (2020) -
Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability
por: Dickman, Andrew, et al.
Publicado: (2017) -
Evaluation of the Accuracy of Current Tubeless Pumps for Continuous Subcutaneous Insulin Infusion
por: Ziegler, Ralph, et al.
Publicado: (2021) -
Continuous subcutaneous insulin infusion: practical issues
por: Saboo, Banshi D., et al.
Publicado: (2012) -
A Continuous Subcutaneous Insulin Infusion Needle Break
por: George, Minu M., et al.
Publicado: (2015)